Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome

Context: Dry eyes has been associated with inflammation and apoptosis of the ocular surface which is responsible for conjunctival goblet cell loss in long term. Aim: To study the efficacy of carboxymethylcellulose and topical cyclosporine A 0.05% in the treatment of dry eyes and their effect on the...

Full description

Bibliographic Details
Main Authors: Sangeeta Shah, Badri P. Badhu, Poonam Lavaju, Santosh Chaudhary, Arvind K. Sinha
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Cogent Medicine
Subjects:
Online Access:http://dx.doi.org/10.1080/2331205X.2017.1321869
_version_ 1818018082323431424
author Sangeeta Shah
Badri P. Badhu
Poonam Lavaju
Santosh Chaudhary
Arvind K. Sinha
author_facet Sangeeta Shah
Badri P. Badhu
Poonam Lavaju
Santosh Chaudhary
Arvind K. Sinha
author_sort Sangeeta Shah
collection DOAJ
description Context: Dry eyes has been associated with inflammation and apoptosis of the ocular surface which is responsible for conjunctival goblet cell loss in long term. Aim: To study the efficacy of carboxymethylcellulose and topical cyclosporine A 0.05% in the treatment of dry eyes and their effect on the density of conjunctival goblet cells (GCD). Settings and design: Hospital based, Randomized clinical trial. Methods and material: A total of 90 patients of dry eyes were enrolled and were randomly divided into two groups of 45 each. Group A was treated with topical cyclosporine A 0.05% twice daily and group B with preservative free carboxymethyl cellulose 0.5% (CMC) four times daily for 6 weeks. Different parameters like dry eye symptoms through visual analogue score (VAS), tear break up time (TBUT), Schirmer’s tests (SCH), fluorescein stain (FLU) and goblet cell density (GCD) were obtained prior to treatment and compared with the results after 6 weeks of treatment. Statistical analysis used: SPSS software, version 12.0. Results: After 6 weeks of treatment both the groups showed significant improvement from baseline values of all the parameters (p < 0.001). Comparison between these two groups after treatment showed that all the parameters except FLU score (p < 0.001) were statistically not significant. Conclusions: Both the topical CMC 0.5% and cyclosporine A 0.05% showed improvement of ocular surface at 6 weeks interval. However, there was no significant difference between the outcome of two groups.
first_indexed 2024-04-14T07:35:27Z
format Article
id doaj.art-0345cc4a423d4190b3c672dfc1d9dc50
institution Directory Open Access Journal
issn 2331-205X
language English
last_indexed 2024-04-14T07:35:27Z
publishDate 2017-01-01
publisher Taylor & Francis Group
record_format Article
series Cogent Medicine
spelling doaj.art-0345cc4a423d4190b3c672dfc1d9dc502022-12-22T02:05:42ZengTaylor & Francis GroupCogent Medicine2331-205X2017-01-014110.1080/2331205X.2017.13218691321869Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndromeSangeeta Shah0Badri P. Badhu1Poonam Lavaju2Santosh Chaudhary3Arvind K. Sinha4BPKIHSBPKIHSBPKIHSBPKIHSBPKIHSContext: Dry eyes has been associated with inflammation and apoptosis of the ocular surface which is responsible for conjunctival goblet cell loss in long term. Aim: To study the efficacy of carboxymethylcellulose and topical cyclosporine A 0.05% in the treatment of dry eyes and their effect on the density of conjunctival goblet cells (GCD). Settings and design: Hospital based, Randomized clinical trial. Methods and material: A total of 90 patients of dry eyes were enrolled and were randomly divided into two groups of 45 each. Group A was treated with topical cyclosporine A 0.05% twice daily and group B with preservative free carboxymethyl cellulose 0.5% (CMC) four times daily for 6 weeks. Different parameters like dry eye symptoms through visual analogue score (VAS), tear break up time (TBUT), Schirmer’s tests (SCH), fluorescein stain (FLU) and goblet cell density (GCD) were obtained prior to treatment and compared with the results after 6 weeks of treatment. Statistical analysis used: SPSS software, version 12.0. Results: After 6 weeks of treatment both the groups showed significant improvement from baseline values of all the parameters (p < 0.001). Comparison between these two groups after treatment showed that all the parameters except FLU score (p < 0.001) were statistically not significant. Conclusions: Both the topical CMC 0.5% and cyclosporine A 0.05% showed improvement of ocular surface at 6 weeks interval. However, there was no significant difference between the outcome of two groups.http://dx.doi.org/10.1080/2331205X.2017.1321869cyclosporine aconjunctival impression cytologygoblet cells
spellingShingle Sangeeta Shah
Badri P. Badhu
Poonam Lavaju
Santosh Chaudhary
Arvind K. Sinha
Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome
Cogent Medicine
cyclosporine a
conjunctival impression cytology
goblet cells
title Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome
title_full Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome
title_fullStr Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome
title_full_unstemmed Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome
title_short Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome
title_sort efficacy of topical carboxymethyl cellulose 0 5 and cyclosporine a 0 05 in dry eye syndrome
topic cyclosporine a
conjunctival impression cytology
goblet cells
url http://dx.doi.org/10.1080/2331205X.2017.1321869
work_keys_str_mv AT sangeetashah efficacyoftopicalcarboxymethylcellulose05andcyclosporinea005indryeyesyndrome
AT badripbadhu efficacyoftopicalcarboxymethylcellulose05andcyclosporinea005indryeyesyndrome
AT poonamlavaju efficacyoftopicalcarboxymethylcellulose05andcyclosporinea005indryeyesyndrome
AT santoshchaudhary efficacyoftopicalcarboxymethylcellulose05andcyclosporinea005indryeyesyndrome
AT arvindksinha efficacyoftopicalcarboxymethylcellulose05andcyclosporinea005indryeyesyndrome